Stock Events

Stock Events

Ernexa Therapeutics 

$0.112000
363
+$0.00+4.58% Today

Statistics

Day High
0.1125
Day Low
0.1125
52W High
0.1125
52W Low
0.112
Volume
177
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17AugExpected
Q4 2022
Q1 2025
Q1 2026
Next
-900
-600.65
-301.3
-1.95
Expected EPS
-3.3
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ERNAW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
ARK Innovation
ARKK
Mkt Cap0
ARK Innovation ETF focuses on disruptive innovation, directly competing with BIGZ's investment in innovative growth companies.
Invesco QQQ Trust Series 1
QQQ
Mkt Cap0
Invesco QQQ Trust tracks the NASDAQ-100 Index, including technology and innovation leaders, competing for similar investor interest.
Vanguard Information Technology
VGT
Mkt Cap0
Vanguard Information Technology ETF invests in tech stocks, overlapping with BIGZ's focus on innovation and growth sectors.
iShares Expanded Tech-Software Sector
IGV
Mkt Cap0
iShares Expanded Tech-Software Sector ETF focuses on software industry, a key area of innovation, competing with BIGZ's tech-oriented investments.
First Trust Dow Jones Internet Index Fund
FDN
Mkt Cap0
First Trust Dow Jones Internet Index Fund invests in internet companies, directly competing with BIGZ's emphasis on innovative and growth companies.
ARK Next Generation Internet
ARKW
Mkt Cap0
ARK Next Generation Internet ETF focuses on internet and tech innovation, competing in the same space as BIGZ.
State Street SPDR FactSet Innovative Technology
XITK
Mkt Cap0
SPDR FactSet Innovative Technology ETF targets technology and innovation, similar to BIGZ's investment strategy.
ROBO Global Robotics and Automation Index
ROBO
Mkt Cap0
ROBO Global Robotics and Automation Index ETF invests in robotics and automation, areas of innovation that BIGZ might also explore.
First Trust Cloud Computing
SKYY
Mkt Cap0
First Trust Cloud Computing ETF focuses on cloud computing companies, competing with BIGZ's investment in innovative tech sectors.

About

Operating in the preclinical phase, Ernexa Therapeutics Inc. is dedicated to advancing therapies based on induced mesenchymal stem cells (iMSC) to combat both solid tumors and autoimmune conditions. Its primary therapeutic, ERNA-101, is an allogeneic iMSC specifically formulated to secrete pro-inflammatory cytokines like IL-7 and IL-15 for the treatment of ovarian cancer. Complementing this, ERNA-102 is another iMSC designed to deliver the anti-inflammatory cytokine IL-10, targeting rheumatoid arthritis. Ernexa Therapeutics has secured a licensing agreement with Factor Bioscience Limited. The company, founded in 2018 and headquartered in Cambridge, Massachusetts, was formerly named Eterna Therapeutics Inc., before officially changing to Ernexa Therapeutics in March 2025.
Show more...
CEO
Mr. Sanjeev Luther
Employees
6
Country
United States
ISIN
US1140821182

Listings

F
DE
8W4.F
XNAS
US
ERNAW
XNAS
US
ERNA
BOATS
BOATS
ERNA.BOATS

0 Comments

Share your thoughts

FAQ

What is Ernexa Therapeutics stock price today?▼
The current price of ERNAW is $0.11 USD — it has increased by +4.58% in the past 24 hours. Watch Ernexa Therapeutics stock price performance more closely on the chart.
What is Ernexa Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ernexa Therapeutics stocks are traded under the ticker ERNAW.
When is the next Ernexa Therapeutics earnings date?▼
Ernexa Therapeutics is going to release the next earnings report on August 17, 2026.
What were Ernexa Therapeutics earnings last quarter?▼
ERNAW earnings for the last quarter are -6.95 USD per share, whereas the estimation was -1.95 USD resulting in a -256.41% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Ernexa Therapeutics have?▼
As of June 15, 2026, the company has 6 employees.
In which sector is Ernexa Therapeutics located?▼
Ernexa Therapeutics operates in the Other sector.
When did Ernexa Therapeutics complete a stock split?▼
The last stock split for Ernexa Therapeutics was on May 04, 2026 with a ratio of 1:25.
Where is Ernexa Therapeutics headquartered?▼
Ernexa Therapeutics is headquartered in Cambridge, United States.